What's in Region Örebro County's pipeline?

Region Örebro County has 10 drugs in our index: 5 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 2 in Phase 1.

Which companies overlap with Region Örebro County's portfolio?

Top competitors by shared drug class: University of Pennsylvania, GlaxoSmithKline, KK Women's and Children's Hospital, Medical University of Vienna, Vanderbilt University Medical Center.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/region-rebro-county.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Region Örebro County — Portfolio Competitive Intelligence Brief

Region Örebro County pipeline: 5 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

5 marketed 0 filed 3 Phase 3 0 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
PlaceboMNTX	PlaceboMNTX	marketed
I/T morphine	I/T morphine	marketed	Opioid analgesic	Mu-opioid receptor (μ-OR)	Pain management
Clonidine Oral Liquid Product	Clonidine Oral Liquid Product	marketed	Alpha-2 adrenergic agonist	Alpha-2 adrenergic receptor	Cardiovascular
RemifentanilMNTX	RemifentanilMNTX	marketed	Opioid agonist with peripheral opioid antagonist	Mu-opioid receptor (agonist: remifentanil; peripheral antagonist: methylnaltrexone)	Anesthesia/Analgesia
FSME-IMMUN Vaccine	FSME-IMMUN Vaccine	marketed	Inactivated viral vaccine	Tick-borne encephalitis virus (TBEV)	Immunology / Infectious Disease
CDK 4/6 inhibitors	CDK 4/6 inhibitors	phase 3	CDK 4/6 inhibitor	CDK4, CDK6	Oncology
Placebo Tab	Placebo Tab	phase 3
ropivacaine, ketorelac and epinephrine	ropivacaine, ketorelac and epinephrine	phase 3	Local anesthetic and NSAID	Sodium channels and prostaglandin synthesis	Pain management

Therapeutic area mix

Pain management · 2
Anesthesia/Analgesia · 1
Cardiovascular · 1
Immunology / Infectious Disease · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

University of Pennsylvania · 2 shared drug classes
GlaxoSmithKline · 2 shared drug classes
KK Women's and Children's Hospital · 2 shared drug classes
Medical University of Vienna · 2 shared drug classes
Vanderbilt University Medical Center · 2 shared drug classes
American University of Beirut Medical Center · 1 shared drug class
Alza Corporation, DE, USA · 1 shared drug class
Ain Shams University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Region Örebro County:

Cite this brief

Drug Landscape (2026). Region Örebro County — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/region-rebro-county. Accessed 2026-05-16.